Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4(+)CD25(+)-regulated events leading to apoptosis

Ítems similars

• A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4(+) T cells
  per: Paas-Rozner, Miri, et al.
  Publicat: (2003)
• A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas–FasL-mediated apoptosis
  per: Venkata Aruna, Badiga, et al.
  Publicat: (2006)
• Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4(+)CD25(+) regulatory cells
  per: Aruna, Badiga Venkata, et al.
  Publicat: (2005)
• The role of CD8(+)CD28(−) regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand
  per: Ben-David, Hava, et al.
  Publicat: (2007)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  per: Paas-Rozner, Miri, et al.
  Publicat: (2000)